New England Journal of Medicine Paper Shows Remdesivir Speeds Recovery for Hospitalized COVID-19 Patients
June 05, 2020
June 05, 2020
FREDERICK, Maryland, June 5 -- The National Institutes of Health's Frederick National Laboratory for Cancer Research issued the following news:
The antiviral treatment remdesivir accelerated recovery time among hospitalized participants with advanced COVID-19 compared to participants who received placebo containing inactive ingredients, according to results of a clinical trial published May 22 (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764) in the New England Journal of M . . .
The antiviral treatment remdesivir accelerated recovery time among hospitalized participants with advanced COVID-19 compared to participants who received placebo containing inactive ingredients, according to results of a clinical trial published May 22 (https://www.nejm.org/doi/full/10.1056/NEJMoa2007764) in the New England Journal of M . . .